Estimating Health State Utilities for Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL) in Mexico and Brazil
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.551
https://www.valueinhealthjournal.com/article/S1098-3015(13)02456-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
531
First Page :
A419
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02456-X&doi=10.1016/j.jval.2013.08.551